NIH unveils clinical trial supply facility; plans service expansion

The NIH Clinical Center's Pharmaceutical Development Section is readying to cash in on a seven-year effort by moving into a new $12-million facility. The June move to the 1,115-square-meter drug-making plant marks a big change from the 743-square-meter workspace it has occupied for 50 years.

The PDS's 20 chemists, pharmacists, pharmacokineticists and technicians produce investigational treatments used in many of the hundreds of the Clinical Center's ongoing studies--about one-third of the 1,000 drugs, including placebos. Drug forms include solid oral dosage, injection, IV, ointments and creams.

NIH hosted reporters on a walk-through in late March.

The center's plans include services provided not just to on-site NIH researchers and clients but also to outside clinical investigators. The current one-shift operation is eventually expected to run 24/7.

- read the article

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.